Atlas Trials

Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

Clinical trial NCT01659853 · COMPLETED

Trial details

NCT number
NCT01659853
Sponsor
Galderma R&D
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
ErythemaRosacea
Start date
2012-09-01
Primary completion
2012-12-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.